Skip to main navigation

Top bar

Biogen.com Information Request Sign up for Alerts Search

Investor Relations

Overview

News

Events Presentations

SEC Filings Annual Reports

Stock Quote & Chart Analyst Coverage Investor FAQs

Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board

News

News

News Category

Year

May 24, 2017

Biogen’s FAMPYRA® Granted Standard Marketing Authorization in European Union for Improvement of Walking in People with MS

May 17, 2017

Biogen to Present at the Bernstein 33rd Annual Strategic Decisions Conference

May 15, 2017

Biogen Acquires Remedy Pharmaceuticals’ CIRARA™ for Large Hemispheric Stroke

April 25, 2017

Biogen Reports First Quarter 2017 Revenues of $2.8 Billion

April 24, 2017

TECFIDERA® and TYSABRI® Data Demonstrate Improved Outcomes with Early MS Treatment

April 24, 2017

Final Phase 3 Study Data Show SPINRAZA® (nusinersen) Significantly Improved Motor Function in Children with Later-Onset Spinal Muscular Atrophy

April 21, 2017

Biogen’s SPINRAZA® (nusinersen) Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

April 18, 2017

Biogen Highlights Advances from Its Neurology Research Programs and Portfolio of Innovative Medicines at AAN Congress

April 13, 2017

Biogen Licenses Phase 2 Anti-Tau Antibody from Bristol-Myers Squibb

March 28, 2017

Biogen to Present Data at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases

Pagination

First page
Previous page
…
Page 7
Page 8
Page 9
Page 10
Current page 11
Page 12
Page 13
Page 14
Page 15
…
Next page
Last page

Displaying 101 - 110 of 647

Footer

Investors
Careers
Our Stories
Contact Us

Follow us

Bottom

Privacy Policy
Terms & Conditions
Forward-Looking Statements
Community Guidelines

Investor Relations

Overview

News

Events & Presentations

Events
Presentations

Financials

SEC Filings
Annual Reports

Stock Information

Stock Quote & Chart
Analyst Coverage
Investor FAQs

Corporate Governance

Governance Documents
Committee Composition & Charters
Leadership
Code of Business Conduct
Contact the Board

Top bar

Biogen.com

Information Request

Sign up for Alerts

Search

Follow us